跳至主要内容
临床试验/DRKS00010280
DRKS00010280已完成不适用

Targin® for Treatment of Parkinson's disease associated severe pain - Efficacy and tolerability in real life - TIPAS

Mundipharma GmbH0 个研究点目标入组 40 人开始时间: 2016年4月8日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 one(—)
性别
All

入选标准

  • Male and female patients aged = 18 years.
  • patients who suffer from diopathic Parkinson's disease stage 1-5 according to Hoehn & Yahr.
  • patients who suffer from severe pain graded in at least 1 question of 1 domain of the King’s Parkinson’s disease pain scale (KPPS) which can, according to the physicians opinion, only adequately be managed with opioid analgesics,
  • patients without contraindication (s) for treatment with Targin® according to summary of product characteristics (SmPC)
  • patients who are not cognitively impaired and able to understand the purpose and importance of the study and complete the questionnaire.
  • patients who were not treated with opioid analgesics within the last 3 months before enrolment
  • patients who give their written consent for study participation and for data privacy policy

排除标准

  • The Observation should not be performed in pregnant women or nursing women as well as women willing to become pregnant during treatment.

研究者

相似试验